621 studies found for:    "Hypertension, Pulmonary"
Show Display Options
RSS Create an RSS feed from your search for:
"Hypertension, Pulmonary"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Latent Pulmonary Hypertension (PH) in Chronic Thromboembolic Pulmonary Hypertension (CTEPH )After Endarterectomy and Influence of Exercise and Respiratory Therapy
Conditions: Pulmonary Hypertension;   Chronic Thromboembolic Pulmonary Hypertension
Interventions: Behavioral: exercise and respiratory therapy;   Other: sedentary control group
2 Not yet recruiting Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension Due to Left Ventricular Dysfunction
Conditions: Pre-capillary Pulmonary Hypertension;   Post-capillary Pulmonary Hypertension;   Left Ventricular Dysfunction
Interventions: Drug: Macitentan;   Drug: Placebo
3 Unknown  Simvatstatin Used to Treat Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: simvastatin
4 Unknown  Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Conditions: Chronic Obstructive Pulmonary Disease;   Hypertension, Pulmonary
Intervention: Drug: DHEA Treatment
5 Recruiting Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults
Conditions: Chronic Obstructive Pulmonary Disease;   Hypertension, Pulmonary
Interventions: Drug: DHEA treatment;   Drug: Placebo
6 Completed Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension
Conditions: Heart Failure, Diastolic;   Hypertension, Pulmonary
Interventions: Drug: bosentan;   Drug: placebo
7 Recruiting Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
8 Completed
Has Results
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
Conditions: Thalassemia;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil
9 Recruiting Aerobic Exercise in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
10 Completed Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
Conditions: Pulmonary Fibrosis;   Hypertension, Pulmonary
Intervention: Drug: Sildenafil (50 mg)
11 Completed Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
12 Terminated A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (BAY63-2521);   Drug: Placebo
13 Recruiting Confirmatory Study of IK-3001 in Japanese Subjects With Peri-/Post-op Pulmonary Hypertension Assoc. With Cardiac Surgery
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Intervention: Drug: IK-3001
14 Completed Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
15 Active, not recruiting
Has Results
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
Conditions: Hypertension, Pulmonary;   Ventricular Dysfunction, Left
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
16 Completed
Has Results
Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.
Conditions: Hypertension, Pulmonary;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Riociguat (Adempas, BAY63-2521) 1.0 mg;   Drug: Riociguat (Adempas, BAY63-2521) 2.5 mg
17 Active, not recruiting Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
18 Enrolling by invitation Right Ventricular Resynchronization Therapy
Conditions: Right Ventricular Failure;   Chronic Thromboembolic Pulmonary Hypertension;   Pulmonary Hypertension
Intervention: Device: Implantation of 3-chamber pacemaker
19 Recruiting EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat(BAY63-2521)
20 Completed Atorvastatin in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Atorvastatin;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years